Paeds Vivas · paediatric-dermatology
Congenital melanocytic naevi and pigmentary birthmarks — branching viva
Branching viva on the congenital pigmentary birthmarks: classifying the CMN by the projected adult size, stratifying the melanoma risk, recognising the neurocutaneous-melanocytosis risk pattern, and counselling the family on the surveillance and the management, branching to the pathophysiology, the surgery, the syndromic cafe-au-lait macule, and the dermal-melanocytosis child-protection distinction.
On this page & tools
Target exams
Branching framework
Open with the one-sentence problem representation. This is a large congenital melanocytic naevus on the posterior axis (the thoracic spine) with multiple satellite nevi, in a well six-week-old girl. The decisive features are the size — the projected adult size falls in the large category — and the posterior-axis location with the satellites, which is the high-risk pattern for the neurocutaneous melanocytosis. State the recognition aloud — the brown, the raised and the hairy, the presence at the birth, the size, and the satellites — before you discuss the management. The examiner is listening for whether you stratify the risk before you reach for the plan. [2] [6]
Name the classification and the size-risk relationship. The CMN is classified by the projected adult size: the small under 1.5 cm, the medium 1.5 to 19.9 cm, the large 20 cm and over, the giant 50 cm and over. The melanoma risk tracks the size — near the population risk for the small and the medium, and elevated and concentrated in the childhood for the large and the giant. Be ready for the probe on the projected adult size: it is the size the lesion will reach in the adult, derived from the body-site-specific growth factor applied to the size at the presentation, and it is the correct denominator because the lesion grows with the child. [2] [1]
Branch to the pathophysiology. The CMN is caused by the postzygotic (mosaic) NRAS codon 61 mutation in the melanocyte lineage. The earlier and the more extensive the mutation, the larger the lesion, the more numerous the satellites, and the greater the chance of the leptomeningeal involvement, because the neural crest gives rise to both the skin and the central-nervous-system melanocytes. Be ready for the probe on the surgery: the prophylactic excision does not eliminate the melanoma risk, because the melanoma may arise in the residual cells, the satellites, or the central nervous system, so the observation and the surveillance, not the routine excision, are the mainstay. [6] [3]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References6Show ledgerHide ledger
- [1]Krengel S, Reyes-Múgica M. Melanoma risk in congenital melanocytic naevi. British Journal of Dermatology, 2017.PMID 28504374
- [2]Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. Journal of the American Academy of Dermatology, 2013.PMID 22982004
- [3]Krengel S, Marghoob AA. Current management approaches for congenital melanocytic nevi. Dermatologic Clinics, 2012.PMID 22800546
- [6]Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. Journal of Investigative Dermatology, 2013.PMID 23392294
- [10]Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatric Clinics of North America, 2000.PMID 10943257
- [11]Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Dermato-Venereologica, 2010.PMID 20107718